King Pharmaceuticals KG General Liability — Year 1
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearOne.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's general liability — year 1.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's general liability — year 1?
- King Pharmaceuticals (KG) reported general liability — year 1 of 5.9% in Q4 2025.
- What does general liability — year 1 mean?
- This metric represents the first year of development for general liability claims, typically used in loss triangle analysis to evaluate early-stage claim frequency and severity. It provides an initial view of underwriting performance for the most recent policy year.